![Christopher J. Stevo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher J. Stevo
Contatto Relazioni con gli Investitori presso
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Profilo
Christopher J.
Stevo currently works at Teva Pharmaceutical Industries Ltd., as SVP-Investor Relations & Competitive Intelligence.
Mr. Stevo also formerly worked at Amundi Asset Management US, Inc., as Vice President & Senior Equity Analyst from 2012 to 2020, Alexion Pharmaceuticals, Inc., as Head-Investor Relations1 from 2020 to 2021, Enron Corp., as Analyst in 1997, Putnam Investment Management LLC, as Senior Vice President & Portfolio Manager from 2011 to 2012, and Pfizer Inc., as Chief Investor Relations Officer & Senior VP from 2021 to 2024.
Mr. Stevo received his Masters Business Admin degree in 1999 from The University of Chicago Booth School of Business and undergraduate degree in 1994 from The Wharton School of the University of Pennsylvania.
Posizioni attive di Christopher J. Stevo
| Società | Posizione | Inizio |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Contatto Relazioni con gli Investitori | - |
Precedenti posizioni note di Christopher J. Stevo
| Società | Posizione | Fine |
|---|---|---|
| PFIZER INC. | Contatto Relazioni con gli Investitori | 01/01/2024 |
| ALEXION PHARMACEUTICALS, INC. | Contatto Relazioni con gli Investitori | 01/07/2021 |
Amundi Asset Management US, Inc.
 Amundi Asset Management US, Inc. Investment ManagersFinance Amundi US selects investments from a wide range of asset classes and employs a variety of styles in managing client assets. Regarding equity securities, the firm employs fundamental and quantitative research to their portfolio management approach. With respect to fixed income securities, their investment professionals consistently apply well established means of identifying potentially rewarding securities. Whether applying top-down analysis that leads to selection of government bonds, or the bottom-up approach that ends with corporate bonds being selected, the investment management team's goal is portfolio construction that matches product objectives and supports investors’ goals. | Analyst-Equity | 01/04/2020 |
Putnam Investment Management LLC
 Putnam Investment Management LLC Investment ManagersFinance PIM is an active, long-term investment manager across the major asset classes. Their analysis of the financial markets is generally based on fundamental analysis and research, but also includes quantitative elements. PIM research is focused on developing both a top-down view of broader market performance and a bottom-up outlook for individual securities. | Analyst-Equity | 02/03/2012 |
Enron Corp.
 Enron Corp. Integrated OilEnergy Minerals Provides energy related services | Corporate Officer/Principal | 30/08/1997 |
Formazione di Christopher J. Stevo
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
83
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Amundi Asset Management US, Inc.
Amundi Asset Management US, Inc. Investment ManagersFinance Amundi US selects investments from a wide range of asset classes and employs a variety of styles in managing client assets. Regarding equity securities, the firm employs fundamental and quantitative research to their portfolio management approach. With respect to fixed income securities, their investment professionals consistently apply well established means of identifying potentially rewarding securities. Whether applying top-down analysis that leads to selection of government bonds, or the bottom-up approach that ends with corporate bonds being selected, the investment management team's goal is portfolio construction that matches product objectives and supports investors’ goals. | Finance |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Enron Corp.
Enron Corp. Integrated OilEnergy Minerals Provides energy related services | Energy Minerals |
Putnam Investment Management LLC
Putnam Investment Management LLC Investment ManagersFinance PIM is an active, long-term investment manager across the major asset classes. Their analysis of the financial markets is generally based on fundamental analysis and research, but also includes quantitative elements. PIM research is focused on developing both a top-down view of broader market performance and a bottom-up outlook for individual securities. | Finance |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
